Our NGS, Microarray and WGS based sequenced DNA data is targeted for Pathogenic and likely pathogenic Mutations to identify the current life expression of the mutation or polymorphisms which then generates the nutritional and pharmacogenetics results to generate the precision drugs conducive to the gene composition yielding personalized supplements and lifestyle guidances to enable epigenetic modifications that ensure wellbeing. We cross information from blood and metabolic biomarkers with the genetic analysis giving a state of the art correlation of the health status of the profiled individual given his current life condition to enable the epigenetic modulation and pharmacogenetics.
In the Transceptar Physician portal the doctor will select the disease(s) indicated in the genetic test result. Then the system will automatically indicate the blood and further diagnostic tests to be done. After results arrive, the nurse will enter the results inside the system, on the patient’s folder, using the patient’s ID number. The system will then calculate: Genetics x Blood Test results and indicate the supplements to be prescribed to the patient.
Transceptar is a leading AI company in health and precision medicine. Its AI-powered genetic testing company generates the most accurate and precise DNA test reports since 2011.